| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.04 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |